BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 27
• 28
• 29
• 30

• Drug Development

  Alnylam Pharmaceuticals Receives Positive Opinion For Orphan Drug Designation In The European Union For ALN-Ttrsc, A Subcutaneously Delivered Rnai Therapeutic For The Treatment Of Transthyretin-Mediated Amyloidosis (ATTR)

  April 2, 2014

   · 

  1 min read
• Pharm Country

  Clinical Conductor CTMS Redefines Clinical Research With First Ever Collaborative CTMS

  April 2, 2014

   · 

  3 min read
• BioCapital

  Drug Information Association 2014 50th Annual Meeting To Examine The Changing Landscape For Bioinnovation

  April 2, 2014

   · 

  2 min read
• Drug Development

  FDA Grants IND Approval For Phase 2a Clinical Trial Using CardioCell’s Itmsc Therapy To Treat Dilated Chronic Heart Failure

  April 2, 2014

   · 

  1 min read
• Qbtech Launches Breakthrough Product In The U.S.: First Test Cleared By FDA To Provide Unbiased Evaluation Of ADHD Treatment

  April 2, 2014

   · 

  1 min read
• Policy

  Third-Party Probe Confirms Novartis AG Staff Covered Up Evidence

  April 2, 2014

   · 

  1 min read